Optical-imaging technology has become one of the most promising approaches in biomedicine, since it can be used to deduce the structure and function of tissues in vivo. However, one limitation to its application is skin cover, which prevents light access to subcutaneous targets. Tissue optical clearing 1 can improve the penetration depth of light by immersing tissues in optical-clearing agents (OCAs), such as glycerol and glucose, with high refractive indices and dermal permeability. Recently, neural circuits of drosophila mushroom bodies were mapped in high-resolution 3D detail under the microscope using OCAs. 2 Such a technique would be useful for subcutaneous observation, although whether OCAs used in vitro are effective and safe for use in vivo has yet to be determined. To address these issues, our research has focused on mechanisms of optical clearing in vivo and biocompatibility of OCAs. Our aim is to develop a noninvasive, controllable optical-clearing technique for opening a 'transparent window' through skin to determine subcutaneous microvascular structures and functions at high resolution.
Figure 1. Images of dermal collagen fibers taken by transmissionelectron microscopy (TEM) and second-harmonic generation (SHG) 10min after injection of optical-clearing agents (OCAs). (a) Blank control, (b) 20, (c) 30, and (d) 75% by volume glycerol.
regularity, which play an important role in the mechanism for OCA-induced optical clearing in skin. 4 These results differ from in vitro immersion experiments of skin, where collagen-fiber dissociation or fracture occurred. 5 While dermal injection allows optical clearing, we were interested in developing noninvasive techniques. Before topical OCAs are used in vivo, we need to evaluate possible effects on tissue function. We used laser-speckle-contrast imaging to observe changes in chick chorioallantoic membranes (CAMs) after application of varying OCA concentrations. 6 We investigated both short-and long-term effects by monitoring changes of blood flow and development of blood vessels in CAMs, respectively. We found that OCAs reduced the local blood-flow velocity and constricted, or blocked, blood vessels. While blood flow recovered to varying degrees, this depended on the OCA type and concentration. The extent to which new blood vessels developed also depended on OCA type and concentration (see Figure 2 ). Observing vasculature in this way provides a new method for determining OCA biocompatibility. Additionally, OCAs are less effective when used topically than when injected subcutaneously. The outermost layer of skin-the stratum corneum (SC)-blocks the majority of the OCA and, thus, diminishes the optical-clearing effect. To reduce the SCbarrier effect, we used a newly developed penetration enhancer, thiazone: benzisothiazol-3(2H)-one-2-butyl-1,1-dioxide. Topical application of a mixture of thiazone and OCA can improve visualization of subcutaneous microvessels. 7 We used laser-speckle temporal-contrast analysis to visualize dermal blood flow at high resolution, which was not previously possible using OCAs alone. Post-imaging treatment with saline allowed skin recovery (see Figure 3) .
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In summary, we have demonstrated that optical clearing is a promising tool for in vivo, noninvasive, and controllable subcutaneous imaging. Combined with optical-imaging technology, such as fluorescence and laser-speckle-contrast imaging, we achieved improved image contrast and resolution. In future, our optical-clearing methods could be used for optical diagnosis of peripheral blood-vessel disease. In particular, the technique will be useful for investigating mechanisms of tumorigenesis and progression as well as evaluating the effectiveness of tumor treatment. These important applications to clinical medicine constitute our ongoing work. Jing Wang is a PhD candidate in biomedical engeering.
